Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon

NCT00951106 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

FED

Sponsor class

Conditions

Malaria, Vivax
Malaria, Falciparum

Interventions

DRUG: Pyrimethamine/sulfdoxine (Fansidar)

Sponsor

Walter Reed Army Institute of Research (WRAIR)